Table 2.

Fibrinogen binding to platelets as determined by flow cytometry

Mean intensity*
Not preincubatedPInhibition after preincubation with anti-Stx1 (%)Inhibition after preincubation with Reopro (%)
Unstimulated platelets 0.42    
Stx1 10 pg/mL 2.18 ns 36 53  
Stx1 100 pg/mL 5.27 < .01 30 82  
Stx1 1 ng/mL 3.04 < .05 55 72  
Stx1 10 ng/mL 4.02 < .005 nt nt  
Stx1B 10 pg/mL 4.39 < .05 nt nt  
Stx1B 100 pg/mL 8.47 < .05 17 nt  
Stx1B 1 ng/mL 4.05 < .05 nt  
Stx1B 10 ng/mL 4.51 < .01 55 nt 
Mean intensity*
Not preincubatedPInhibition after preincubation with anti-Stx1 (%)Inhibition after preincubation with Reopro (%)
Unstimulated platelets 0.42    
Stx1 10 pg/mL 2.18 ns 36 53  
Stx1 100 pg/mL 5.27 < .01 30 82  
Stx1 1 ng/mL 3.04 < .05 55 72  
Stx1 10 ng/mL 4.02 < .005 nt nt  
Stx1B 10 pg/mL 4.39 < .05 nt nt  
Stx1B 100 pg/mL 8.47 < .05 17 nt  
Stx1B 1 ng/mL 4.05 < .05 nt  
Stx1B 10 ng/mL 4.51 < .01 55 nt 

ns indicates not significant; for other abbreviations, see Table 1.

*

Numbers represent the median of mean fluorescence intensity of the entire cell population after subtraction of the background fluorescence (chicken-antihuman insulin-FITC). Results from 6 experiments for Stx1 and 5 experiments for Stx1B are presented. Inhibition experiments with anti-Stx1 antibody were carried out 4 times with Stx1 and twice with Stx1B. Inhibition experiments with Reopro were carried out twice.P values compare the median for each stimulant with the unstimulated platelets.